Literature DB >> 29049531

Human Epidermal Growth Factor Receptor 2 as a Molecular Biomarker for Metastatic Colorectal Cancer.

Andrea Sartore-Bianchi1, Silvia Marsoni1,2, Salvatore Siena1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29049531     DOI： 10.1001/jamaoncol.2017.3323

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  10 in total

1.  HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer.

Authors:  Andrea Sartore-Bianchi; Alessio Amatu; Luca Porcu; Silvia Ghezzi; Sara Lonardi; Francesco Leone; Francesca Bergamo; Elisabetta Fenocchio; Erika Martinelli; Beatrice Borelli; Federica Tosi; Patrizia Racca; Emanuele Valtorta; Emanuela Bonoldi; Cosimo Martino; Caterina Vaghi; Giovanna Marrapese; Fortunato Ciardiello; Vittorina Zagonel; Alberto Bardelli; Livio Trusolino; Valter Torri; Silvia Marsoni; Salvatore Siena
Journal:  Oncologist       Date:  2019-04-05

Review 2.  Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.

Authors:  S Siena; A Sartore-Bianchi; S Marsoni; H I Hurwitz; S J McCall; F Penault-Llorca; S Srock; A Bardelli; L Trusolino
Journal:  Ann Oncol       Date:  2018-05-01       Impact factor: 32.976

Review 3.  Precision Medicine in Non Communicable Diseases.

Authors:  Mandana Hasanzad; Negar Sarhangi; Hamid Reza Aghaei Meybodi; Shekoufeh Nikfar; Fatemeh Khatami; Bagher Larijani
Journal:  Int J Mol Cell Med       Date:  2019-07-25

4.  The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review.

Authors:  Roberta Lombardo; Federica Tosi; Annunziata Nocerino; Katia Bencardino; Valentina Gambi; Riccardo Ricotta; Francesco Spina; Salvatore Siena; Andrea Sartore-Bianchi
Journal:  Front Oncol       Date:  2020-05-08       Impact factor: 6.244

5.  Candidate Molecular Biomarkers for the Non- Invasive Detection of Colorectal Cancer using Gene Expression Profiling.

Authors:  Mohammad Shafiei; Mahdi Alemrajabi; Ali Najafi; Amir Homayoun Keihan; Masoud Reza Sohrabi
Journal:  Iran J Pathol       Date:  2021-03-02

Review 6.  Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development.

Authors:  William H Gmeiner
Journal:  Onco Targets Ther       Date:  2021-03-25       Impact factor: 4.147

Review 7.  Genetic and biological hallmarks of colorectal cancer.

Authors:  Jiexi Li; Xingdi Ma; Deepavali Chakravarti; Shabnam Shalapour; Ronald A DePinho
Journal:  Genes Dev       Date:  2021-06       Impact factor: 11.361

Review 8.  Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer.

Authors:  Chiara Guarini; Teresa Grassi; Gaetano Pezzicoli; Camillo Porta
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

9.  Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.

Authors:  Marc Peeters; Timothy Price; Julien Taieb; Michael Geissler; Fernando Rivera; Jean-Luc Canon; George Pentheroudakis; Reija Koukakis; Peter Burdon; Salvatore Siena
Journal:  Br J Cancer       Date:  2018-07-17       Impact factor: 7.640

10.  Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications.

Authors:  Ecaterina E Ileana Dumbrava; Kavitha Balaji; Kanwal Raghav; Kenneth Hess; Milind Javle; Mariela Blum-Murphy; Jaffer Ajani; Scott Kopetz; Russell Broaddus; Mark Routbort; Mehmet Demirhan; Xiaofeng Zheng; Shubham Pant; Apostolia M Tsimberidou; Vivek Subbiah; David S Hong; Jordi Rodon; Kenna M Shaw; Sarina A Piha-Paul; Funda Meric-Bernstam
Journal:  JCO Precis Oncol       Date:  2019-10-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.